Ongoing concerns about marketing practices have taken the shine of a report suggesting Big Pharma efforts have improved parients' access to drugs in developing countries over the past two years.
Several international CMOs will establish themselves in Russia over the next few years as pharma looks to satisfy the country's manufacturing policies, the CEO of R-Pharm predicts.
The six biggest CROs look set to see revenues grow in the next few years with both Parexel and Icon predicting the group will capture a larger share of research spend.
Cost cutting has sustained pharma profits in the faltering global economy, however top executives are starting to realise that reducing R&D capacity may not have been the smartest move in an era of weak pipelines and impending patent expiry, according...
The current big pharma business model is not sustainable for the
future and will need to change, delegates heard at the recent
Financial Times (FT) global Pharmaceuticals and Biotechnology
Conference.
Nomeco, Denmark's biggest pharma wholesaler, has won a large
pre-wholesaling and logistics contract with Iceland's Actavis
covering the Nordic countries, typifying the regional shift in this
evolving sector of pharmaceutical...